Evidence map›Paper›PMID 38731629›Full record

ArticleMolecules (Basel, Switzerland)2024

Design, Synthesis and Biological Activity of Novel Methoxy- and Hydroxy-Substituted

Anja Beč, Katarina Zlatić, Mihailo Banjanac, Vedrana Radovanović, Kristina Starčević, Marijeta Kralj, Marijana Hranjec

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review of promising benzimidazole-based anticancer agents (2023-2026).Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  2. Review
  3. Heterocycles in Medicinal Chemistry II.Molecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anja BečDepartment of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev Trg 19, 10000 Zagreb, Croatia.
Katarina ZlatićDivision of Molecular Medicine, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0002-1375-1677
Mihailo BanjanacPharmacology In Vitro, Selvita Ltd., Prilaz baruna Filipovića 29, 10000 Zagreb, Croatia.
Vedrana RadovanovićPharmacology In Vitro, Selvita Ltd., Prilaz baruna Filipovića 29, 10000 Zagreb, Croatia.
Kristina StarčevićDepartment of Chemistry and Biochemistry, Faculty of Veterinary Medicine, University of Zagreb, Heinzelova 55, 10000 Zagreb, Croatia.ORCID 0000-0002-2606-7807
Marijeta KraljDivision of Molecular Medicine, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0002-7165-2722
Marijana HranjecDepartment of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev Trg 19, 10000 Zagreb, Croatia.ORCID 0000-0002-3994-0054

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work presents the design, synthesis and biological activity of novel

Indexed as

Antineoplastic AgentsAntioxidantsBenzimidazolesCell ProliferationDrug DesignAmidesAnti-Bacterial AgentsHumansMCF-7 CellsMicrobial Sensitivity TestsMolecular StructureOxidative StressStructure-Activity RelationshipAmidesAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsbenzimidazoleBenzimidazolesantibacterial activityantioxidative activityantiproliferative activitybenzimidazolescarboxamidesROS

Identifiers

PMID38731629
PMCPMC11085308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.